Dr Reddy's launches generic arthritis drug in US market

"The launch of product is an important addition to our pain/analgesics portfolio of over-the-counter (OTC) products, and represents our continued commitment to the private label OTC space," Dr Reddy's Laboratories North America Generics CEO Marc Kikuchi said in a statement.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2ZlUzky
via IFTTT